Update

Summary by AI ^BETAClose X

Fortis Frontier PLC will be suspended from trading on AIM effective 7:30 am on May 11, 2026, as it will not complete a reverse takeover by the May 10 deadline, in accordance with AIM Rule 15. The company, which had approximately £3.7 million in cash as of April 30, 2026, is actively seeking acquisition opportunities to enhance shareholder value. If a suitable acquisition is not completed by November 11, 2026, leading to a potential cancellation of admission under AIM Rule 41, the directors will explore listing on the Aquis Stock Exchange to maintain an orderly market.

Disclaimer*

Fortis Frontier PLC

05 May 2026

Fortis Frontier PLC

("Fortis Frontier" or the "Company")

Update

Fortis Frontier PLC (AIM: FORF), an AIM Rule 15 cash shell (formerly MyHealthChecked PLC), announces that it will not be in a position to acquire another company or business by way of a reverse takeover on or before 10 May 2026, in accordance with AIM Rule 15. As a result, the Company will be suspended from trading on AIM pursuant to AIM Rule 40 with effect from 7:30 am on 11 May 2026.

As previously reported, the Board believes that there are potentially attractive acquisition opportunities available, and that as an AIM Rule 15 Cash Shell with surplus cash, the Company is well positioned to negotiate an accretive transaction which could increase Shareholder value. Although the Board is confident that a suitable acquisition can be identified within a reasonable timescale the Directors are taking time to carefully consider and evaluate all such approaches to ensure the most appropriate strategic option is chosen in the best interests of the Company and its Shareholders.

If the Company's shares remain suspended for six months, admission of the Company's shares will be cancelled. However, if the Company was to lose its AIM listing under AIM Rule 41 (i.e. the Company is unable to complete an acquisition in line with AIM Rule 15 by 11 November 2026) the Directors would fully explore seeking an alternative listing on the Aquis Stock Exchange in order to maintain an orderly market in the Ordinary Shares.

Following the recent share buybacks, and settlement of associated costs, the Company had cash (unaudited) of approximately £3.7m as at 30 April 2026.

For further information contact:

Fortis Frontier PLC	www.fortisfrontierplc-ir.com
Adam Reynolds, Executive Chairman	via Walbrook PR

SPARK Advisory Partners Limited (NOMAD)	Tel: +44 (0)20 3368 3550
Neil Baldwin / Dillon Wall

Singer Capital Markets (Broker)	Tel: +44 (0)20 7496 3000
James Serjeant / Russell Cook / Amber Higgs

Walbrook PR Ltd (Media & IR)	Tel: +44 (0)20 7933 8780 or fortisfrontier@walbrookpr.com
Paul McManus / Alice Woodings	Mob: +44 (0)7980 541 893 / +44(0)7407 804 654

About Fortis Frontier PLC

On 10 November 2025 MyHealthChecked PLC completed the disposal of its trading subsidiary, Concepta Diagnostics Limited, becoming an AIM Rule 15 Cash Shell, as defined in the AIM Rules for Companies. On the same day the Company changed its name to Fortis Frontier PLC. The Board is now carefully considering the strategic options available to it in order to maximise shareholder value.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END